Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 8 | 2021 | 64 | 3.790 |
Why?
|
Proto-Oncogene Protein c-ets-1 | 14 | 2021 | 63 | 2.700 |
Why?
|
GATA3 Transcription Factor | 20 | 2016 | 154 | 2.630 |
Why?
|
Th2 Cells | 23 | 2019 | 1056 | 2.380 |
Why?
|
T-Lymphocytes, Helper-Inducer | 8 | 2021 | 974 | 1.420 |
Why?
|
Arthritis, Rheumatoid | 8 | 2023 | 3752 | 1.370 |
Why?
|
Interleukin-4 | 15 | 2016 | 1146 | 1.310 |
Why?
|
Cell Differentiation | 32 | 2021 | 11514 | 1.170 |
Why?
|
T-Lymphocyte Subsets | 11 | 2019 | 1798 | 1.050 |
Why?
|
Citrulline | 2 | 2016 | 106 | 1.040 |
Why?
|
Th1 Cells | 12 | 2013 | 1027 | 1.000 |
Why?
|
Thymus Gland | 8 | 2009 | 1243 | 0.880 |
Why?
|
Proto-Oncogene Proteins c-maf | 18 | 2015 | 69 | 0.800 |
Why?
|
DNA-Binding Proteins | 25 | 2019 | 9586 | 0.800 |
Why?
|
Trans-Activators | 12 | 2008 | 2852 | 0.780 |
Why?
|
Elastic Tissue | 1 | 2021 | 66 | 0.750 |
Why?
|
Lymphocyte Activation | 9 | 2012 | 5463 | 0.720 |
Why?
|
Natural Killer T-Cells | 2 | 2021 | 322 | 0.690 |
Why?
|
Gene Expression Regulation | 21 | 2022 | 11874 | 0.680 |
Why?
|
T-Lymphocytes | 15 | 2016 | 10175 | 0.600 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2023 | 515 | 0.590 |
Why?
|
Extracellular Matrix Proteins | 1 | 2021 | 829 | 0.560 |
Why?
|
Proto-Oncogene Proteins | 17 | 2005 | 4512 | 0.560 |
Why?
|
DNA, Complementary | 4 | 2015 | 1989 | 0.530 |
Why?
|
Th17 Cells | 3 | 2019 | 793 | 0.530 |
Why?
|
NFATC Transcription Factors | 6 | 2013 | 389 | 0.520 |
Why?
|
Leukocytes, Mononuclear | 3 | 2021 | 1835 | 0.510 |
Why?
|
Promoter Regions, Genetic | 16 | 2015 | 5780 | 0.490 |
Why?
|
Lung Diseases, Interstitial | 1 | 2023 | 918 | 0.480 |
Why?
|
Hydrolases | 1 | 2015 | 147 | 0.480 |
Why?
|
Mice, Knockout | 27 | 2021 | 14389 | 0.460 |
Why?
|
Nuclear Proteins | 9 | 2004 | 5789 | 0.440 |
Why?
|
Mice | 56 | 2023 | 81368 | 0.440 |
Why?
|
Cytokines | 15 | 2016 | 7373 | 0.430 |
Why?
|
Recombinant Proteins | 3 | 2021 | 6520 | 0.420 |
Why?
|
Interleukin-2 | 4 | 2016 | 1887 | 0.420 |
Why?
|
Transcription Factors | 18 | 2013 | 12116 | 0.410 |
Why?
|
Proteins | 2 | 2023 | 6030 | 0.390 |
Why?
|
Animals | 65 | 2023 | 168201 | 0.380 |
Why?
|
Colitis | 4 | 2016 | 1234 | 0.380 |
Why?
|
Homeostasis | 3 | 2019 | 3321 | 0.360 |
Why?
|
Receptors, Antigen, T-Cell | 10 | 2008 | 2546 | 0.360 |
Why?
|
Disease | 1 | 2016 | 670 | 0.350 |
Why?
|
Interleukin-7 | 1 | 2010 | 143 | 0.350 |
Why?
|
Cell Polarity | 1 | 2013 | 635 | 0.340 |
Why?
|
Repressor Proteins | 5 | 2005 | 2985 | 0.330 |
Why?
|
Mice, Transgenic | 17 | 2022 | 9529 | 0.320 |
Why?
|
Interleukin-13 | 4 | 2011 | 392 | 0.320 |
Why?
|
Protein Processing, Post-Translational | 4 | 2023 | 1971 | 0.310 |
Why?
|
Alternative Splicing | 2 | 2012 | 1088 | 0.310 |
Why?
|
Enhancer Elements, Genetic | 7 | 2008 | 1360 | 0.300 |
Why?
|
Molecular Targeted Therapy | 1 | 2019 | 2812 | 0.290 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 433 | 0.280 |
Why?
|
Cell Lineage | 2 | 2009 | 2554 | 0.270 |
Why?
|
Autoantibodies | 1 | 2015 | 2115 | 0.270 |
Why?
|
Blotting, Western | 5 | 2014 | 5034 | 0.260 |
Why?
|
Cell Nucleus | 3 | 2015 | 2894 | 0.260 |
Why?
|
Molecular Sequence Data | 17 | 2013 | 17629 | 0.250 |
Why?
|
Down-Regulation | 4 | 2012 | 2915 | 0.240 |
Why?
|
Killer Cells, Natural | 3 | 2008 | 2191 | 0.240 |
Why?
|
Immunity, Innate | 3 | 2016 | 3045 | 0.240 |
Why?
|
Transcription, Genetic | 10 | 2010 | 7583 | 0.230 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2012 | 4571 | 0.220 |
Why?
|
Interleukin-10 | 7 | 2012 | 1172 | 0.210 |
Why?
|
Atrial Appendage | 1 | 2007 | 278 | 0.210 |
Why?
|
CD4-Positive T-Lymphocytes | 8 | 2008 | 4366 | 0.210 |
Why?
|
Macrophages | 3 | 2014 | 5758 | 0.210 |
Why?
|
Proto-Oncogene Proteins c-rel | 1 | 2002 | 71 | 0.210 |
Why?
|
Syndecan-2 | 1 | 2022 | 23 | 0.200 |
Why?
|
Prosthesis Implantation | 1 | 2007 | 591 | 0.200 |
Why?
|
Protein Binding | 9 | 2015 | 9345 | 0.200 |
Why?
|
Milk Proteins | 1 | 2002 | 162 | 0.200 |
Why?
|
Mice, Inbred C57BL | 12 | 2015 | 22115 | 0.190 |
Why?
|
Feedback, Physiological | 1 | 2004 | 475 | 0.190 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2014 | 2152 | 0.190 |
Why?
|
Receptors, Interleukin-2 | 1 | 2002 | 561 | 0.180 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 3 | 2009 | 897 | 0.180 |
Why?
|
Transcriptional Activation | 7 | 2015 | 1755 | 0.180 |
Why?
|
Introns | 2 | 2006 | 968 | 0.180 |
Why?
|
Echocardiography, Transesophageal | 1 | 2007 | 1085 | 0.180 |
Why?
|
Phospholipases A | 1 | 2001 | 204 | 0.180 |
Why?
|
Immunoglobulin A | 1 | 2023 | 978 | 0.170 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2015 | 1169 | 0.170 |
Why?
|
Mice, Inbred BALB C | 11 | 2012 | 6188 | 0.170 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 2 | 2021 | 799 | 0.170 |
Why?
|
T-Box Domain Proteins | 4 | 2005 | 469 | 0.170 |
Why?
|
Signal Transduction | 9 | 2019 | 23416 | 0.170 |
Why?
|
Cloning, Molecular | 6 | 2004 | 4172 | 0.160 |
Why?
|
Interferon-gamma | 6 | 2008 | 3145 | 0.160 |
Why?
|
Proto-Oncogenes | 3 | 1999 | 321 | 0.160 |
Why?
|
Base Sequence | 12 | 2013 | 12421 | 0.160 |
Why?
|
Alcohol Oxidoreductases | 1 | 2019 | 168 | 0.160 |
Why?
|
Aldehyde Dehydrogenase | 1 | 2019 | 146 | 0.160 |
Why?
|
Zinc Fingers | 3 | 2002 | 578 | 0.160 |
Why?
|
Immunoglobulin M | 1 | 2023 | 1526 | 0.160 |
Why?
|
Transfection | 5 | 2014 | 5766 | 0.160 |
Why?
|
Intracellular Space | 1 | 2019 | 197 | 0.160 |
Why?
|
Amino Acid Sequence | 9 | 2010 | 13441 | 0.150 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2002 | 790 | 0.150 |
Why?
|
Ionomycin | 2 | 2008 | 110 | 0.150 |
Why?
|
Biological Assay | 1 | 2021 | 626 | 0.150 |
Why?
|
Humans | 48 | 2023 | 760617 | 0.150 |
Why?
|
Pulmonary Fibrosis | 1 | 2022 | 505 | 0.150 |
Why?
|
Respiratory Hypersensitivity | 1 | 2019 | 274 | 0.150 |
Why?
|
Integrases | 1 | 2020 | 518 | 0.140 |
Why?
|
Membrane Proteins | 1 | 2014 | 7847 | 0.140 |
Why?
|
Lung Injury | 1 | 2022 | 422 | 0.140 |
Why?
|
DNA, Catalytic | 1 | 2016 | 5 | 0.140 |
Why?
|
Phosphofructokinase-2 | 1 | 2016 | 33 | 0.140 |
Why?
|
Tetradecanoylphorbol Acetate | 2 | 2008 | 817 | 0.140 |
Why?
|
Interleukins | 3 | 2015 | 783 | 0.140 |
Why?
|
Calcium-Binding Proteins | 1 | 2021 | 1066 | 0.130 |
Why?
|
Gene Targeting | 2 | 1999 | 837 | 0.130 |
Why?
|
Carrier Proteins | 1 | 2009 | 4935 | 0.130 |
Why?
|
Basophils | 2 | 2016 | 407 | 0.130 |
Why?
|
STAT6 Transcription Factor | 4 | 2011 | 194 | 0.130 |
Why?
|
Models, Biological | 1 | 2012 | 9461 | 0.130 |
Why?
|
Hypersensitivity | 3 | 2011 | 1167 | 0.120 |
Why?
|
Protein Isoforms | 2 | 2012 | 1697 | 0.120 |
Why?
|
RNA, Small Interfering | 2 | 2014 | 3419 | 0.120 |
Why?
|
Structure-Activity Relationship | 1 | 2020 | 3074 | 0.120 |
Why?
|
Phosphotyrosine | 1 | 2015 | 456 | 0.120 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2015 | 328 | 0.110 |
Why?
|
Protein Structure, Tertiary | 3 | 2014 | 3792 | 0.110 |
Why?
|
Flow Cytometry | 4 | 2014 | 5863 | 0.110 |
Why?
|
Immune Tolerance | 2 | 2015 | 2299 | 0.110 |
Why?
|
Peptides, Cyclic | 1 | 2015 | 392 | 0.110 |
Why?
|
Interleukin-12 | 3 | 2006 | 577 | 0.110 |
Why?
|
Cells, Cultured | 11 | 2012 | 18937 | 0.110 |
Why?
|
src-Family Kinases | 1 | 2015 | 535 | 0.110 |
Why?
|
Spleen | 5 | 2006 | 2286 | 0.100 |
Why?
|
Up-Regulation | 5 | 2012 | 4117 | 0.100 |
Why?
|
Thrombosis | 1 | 2007 | 2943 | 0.100 |
Why?
|
Mice, Inbred ICR | 2 | 2004 | 364 | 0.100 |
Why?
|
Dextran Sulfate | 1 | 2013 | 258 | 0.100 |
Why?
|
Lymphocytes | 2 | 2016 | 2604 | 0.100 |
Why?
|
Toll-Like Receptor 4 | 1 | 2015 | 578 | 0.100 |
Why?
|
Epitopes, T-Lymphocyte | 2 | 2008 | 825 | 0.100 |
Why?
|
Adipocytes | 1 | 1998 | 1187 | 0.100 |
Why?
|
Mast Cells | 1 | 1999 | 1392 | 0.100 |
Why?
|
Histone Deacetylase 1 | 1 | 2012 | 133 | 0.090 |
Why?
|
Interleukin-7 Receptor alpha Subunit | 1 | 2010 | 50 | 0.090 |
Why?
|
Cell Line, Tumor | 4 | 2015 | 16967 | 0.090 |
Why?
|
Binding Sites | 7 | 2006 | 6051 | 0.090 |
Why?
|
Protein Transport | 2 | 2013 | 1966 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-ets | 4 | 2005 | 315 | 0.090 |
Why?
|
Protein Inhibitors of Activated STAT | 1 | 2010 | 30 | 0.090 |
Why?
|
Gene Knockout Techniques | 1 | 2013 | 801 | 0.090 |
Why?
|
Luciferases | 1 | 2012 | 712 | 0.090 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2015 | 15908 | 0.090 |
Why?
|
Small Ubiquitin-Related Modifier Proteins | 1 | 2010 | 68 | 0.090 |
Why?
|
Core Binding Factor Alpha 3 Subunit | 1 | 2009 | 57 | 0.080 |
Why?
|
Genes, Regulator | 1 | 1990 | 373 | 0.080 |
Why?
|
Immunoprecipitation | 1 | 2012 | 876 | 0.080 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2009 | 53 | 0.080 |
Why?
|
Melanoma, Experimental | 1 | 2012 | 561 | 0.080 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2010 | 199 | 0.080 |
Why?
|
Ovalbumin | 2 | 2008 | 675 | 0.080 |
Why?
|
Isoenzymes | 1 | 2014 | 1687 | 0.080 |
Why?
|
3T3 Cells | 2 | 2002 | 1085 | 0.080 |
Why?
|
Interleukin-2 Receptor beta Subunit | 1 | 2008 | 25 | 0.080 |
Why?
|
Female | 17 | 2019 | 392148 | 0.080 |
Why?
|
Energy Metabolism | 1 | 2019 | 2878 | 0.080 |
Why?
|
Atrial Fibrillation | 1 | 2007 | 5031 | 0.080 |
Why?
|
Lymphopoiesis | 1 | 2009 | 133 | 0.080 |
Why?
|
Immunity, Cellular | 1 | 2014 | 1550 | 0.080 |
Why?
|
Middle Aged | 7 | 2021 | 220584 | 0.080 |
Why?
|
Conserved Sequence | 2 | 2009 | 1162 | 0.080 |
Why?
|
Kinetics | 2 | 2008 | 6370 | 0.070 |
Why?
|
Interleukin-12 Subunit p40 | 2 | 2005 | 57 | 0.070 |
Why?
|
Lipopolysaccharides | 1 | 2015 | 2202 | 0.070 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2019 | 4341 | 0.070 |
Why?
|
Leucine Zippers | 2 | 2004 | 116 | 0.070 |
Why?
|
Proteomics | 1 | 2021 | 3836 | 0.070 |
Why?
|
DNA Primers | 1 | 2012 | 2817 | 0.070 |
Why?
|
Monocytes | 2 | 2015 | 2565 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-myb | 1 | 2007 | 78 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 3800 | 0.070 |
Why?
|
Microscopy, Confocal | 1 | 2013 | 1970 | 0.070 |
Why?
|
GATA4 Transcription Factor | 1 | 2008 | 124 | 0.070 |
Why?
|
Multiprotein Complexes | 1 | 2013 | 1118 | 0.070 |
Why?
|
Tumor Cells, Cultured | 3 | 2002 | 6126 | 0.070 |
Why?
|
NF-kappa B | 3 | 2005 | 2481 | 0.070 |
Why?
|
Interleukin-3 | 1 | 2008 | 425 | 0.070 |
Why?
|
CD40 Ligand | 1 | 2008 | 521 | 0.070 |
Why?
|
Galactosylceramides | 1 | 2006 | 92 | 0.070 |
Why?
|
Mice, Mutant Strains | 2 | 2008 | 1748 | 0.070 |
Why?
|
Lymph Nodes | 3 | 2008 | 3461 | 0.070 |
Why?
|
Retinoid X Receptors | 1 | 2006 | 91 | 0.070 |
Why?
|
Tissue Distribution | 2 | 2001 | 2261 | 0.070 |
Why?
|
Proline | 1 | 2008 | 455 | 0.070 |
Why?
|
Treatment Outcome | 3 | 2021 | 64568 | 0.060 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2015 | 2425 | 0.060 |
Why?
|
Lung | 3 | 2022 | 9998 | 0.060 |
Why?
|
Chloramphenicol O-Acetyltransferase | 2 | 1998 | 221 | 0.060 |
Why?
|
Antigen Presentation | 2 | 2008 | 1250 | 0.060 |
Why?
|
Methionine | 1 | 2008 | 572 | 0.060 |
Why?
|
Kruppel-Like Transcription Factors | 3 | 2006 | 504 | 0.060 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2009 | 3077 | 0.060 |
Why?
|
Male | 11 | 2016 | 360358 | 0.060 |
Why?
|
Interleukin-17 | 2 | 2008 | 911 | 0.060 |
Why?
|
Aged | 6 | 2021 | 169042 | 0.060 |
Why?
|
Leukotrienes | 1 | 2006 | 231 | 0.060 |
Why?
|
Exons | 2 | 2007 | 2381 | 0.060 |
Why?
|
Immunoblotting | 2 | 2002 | 1646 | 0.060 |
Why?
|
Injections, Intravenous | 1 | 2006 | 1376 | 0.060 |
Why?
|
Pneumonia | 2 | 2006 | 2143 | 0.060 |
Why?
|
Protein Subunits | 2 | 2005 | 942 | 0.060 |
Why?
|
Epidermis | 1 | 2006 | 527 | 0.060 |
Why?
|
Jurkat Cells | 2 | 2008 | 740 | 0.060 |
Why?
|
RNA-Binding Proteins | 2 | 2002 | 1890 | 0.050 |
Why?
|
Antibodies | 2 | 2008 | 2414 | 0.050 |
Why?
|
Amino Acid Substitution | 1 | 2008 | 1739 | 0.050 |
Why?
|
RNA, Messenger | 2 | 2016 | 12758 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2021 | 20074 | 0.050 |
Why?
|
STAT4 Transcription Factor | 1 | 2002 | 93 | 0.050 |
Why?
|
Mutation, Missense | 1 | 2012 | 2570 | 0.050 |
Why?
|
Crosses, Genetic | 1 | 2004 | 750 | 0.050 |
Why?
|
Gene Deletion | 2 | 2008 | 2661 | 0.050 |
Why?
|
Restriction Mapping | 3 | 1999 | 851 | 0.050 |
Why?
|
Angiotensin II | 1 | 2005 | 849 | 0.050 |
Why?
|
Receptor-Like Protein Tyrosine Phosphatases, Class 3 | 1 | 2022 | 25 | 0.050 |
Why?
|
Disease Models, Animal | 5 | 2016 | 18221 | 0.050 |
Why?
|
HEK293 Cells | 3 | 2019 | 4269 | 0.050 |
Why?
|
Sequence Alignment | 2 | 2010 | 2178 | 0.050 |
Why?
|
Apoptosis | 4 | 2008 | 9476 | 0.050 |
Why?
|
Phylogeny | 1 | 2009 | 2806 | 0.050 |
Why?
|
Sirolimus | 1 | 2009 | 1533 | 0.050 |
Why?
|
Cell Line | 6 | 2010 | 15576 | 0.050 |
Why?
|
Phosphorylation | 2 | 2015 | 8311 | 0.050 |
Why?
|
Two-Hybrid System Techniques | 2 | 2015 | 460 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2008 | 4570 | 0.050 |
Why?
|
Linear Models | 1 | 2012 | 5866 | 0.050 |
Why?
|
STAT5 Transcription Factor | 1 | 2002 | 265 | 0.050 |
Why?
|
Cell Survival | 3 | 2007 | 5780 | 0.050 |
Why?
|
Sp1 Transcription Factor | 1 | 2022 | 140 | 0.050 |
Why?
|
DNA | 6 | 2000 | 7196 | 0.050 |
Why?
|
Ischemic Attack, Transient | 1 | 2007 | 874 | 0.050 |
Why?
|
Forkhead Transcription Factors | 1 | 2008 | 1614 | 0.050 |
Why?
|
Cysteine | 1 | 2006 | 891 | 0.050 |
Why?
|
Case-Control Studies | 2 | 2016 | 22148 | 0.050 |
Why?
|
Cell Division | 3 | 2004 | 4457 | 0.050 |
Why?
|
Bleomycin | 1 | 2022 | 494 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2007 | 1404 | 0.050 |
Why?
|
Transforming Growth Factor beta | 1 | 2008 | 1963 | 0.050 |
Why?
|
Fibrosarcoma | 1 | 2002 | 308 | 0.050 |
Why?
|
Cell Proliferation | 5 | 2008 | 10432 | 0.050 |
Why?
|
Immunoglobulins | 2 | 2006 | 850 | 0.040 |
Why?
|
Sequence Analysis | 1 | 2001 | 240 | 0.040 |
Why?
|
COS Cells | 1 | 2002 | 1130 | 0.040 |
Why?
|
Genetic Loci | 1 | 2009 | 2624 | 0.040 |
Why?
|
Prognosis | 1 | 2021 | 29600 | 0.040 |
Why?
|
Calcium | 1 | 2013 | 5717 | 0.040 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2009 | 2057 | 0.040 |
Why?
|
Chromosome Mapping | 2 | 2000 | 4611 | 0.040 |
Why?
|
Prosthesis Design | 1 | 2007 | 2114 | 0.040 |
Why?
|
Mice, SCID | 1 | 2005 | 2625 | 0.040 |
Why?
|
Adult | 5 | 2019 | 220969 | 0.040 |
Why?
|
HeLa Cells | 2 | 2019 | 3087 | 0.040 |
Why?
|
COP-Coated Vesicles | 1 | 2019 | 39 | 0.040 |
Why?
|
Crystallins | 1 | 1999 | 75 | 0.040 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2009 | 2821 | 0.040 |
Why?
|
Precipitin Tests | 1 | 2000 | 813 | 0.040 |
Why?
|
Starvation | 1 | 2019 | 141 | 0.040 |
Why?
|
Recombinant Fusion Proteins | 2 | 2010 | 3730 | 0.040 |
Why?
|
Interleukin-5 | 3 | 2006 | 269 | 0.040 |
Why?
|
Mass Screening | 1 | 2014 | 5424 | 0.040 |
Why?
|
Fetus | 2 | 2002 | 1862 | 0.040 |
Why?
|
Lipid Metabolism | 1 | 2006 | 1896 | 0.040 |
Why?
|
Species Specificity | 1 | 2002 | 2411 | 0.040 |
Why?
|
Pulmonary Artery | 1 | 2007 | 1927 | 0.040 |
Why?
|
Immunologic Memory | 1 | 2004 | 1355 | 0.040 |
Why?
|
Aorta | 1 | 2005 | 2041 | 0.040 |
Why?
|
Cell Hypoxia | 1 | 2019 | 656 | 0.030 |
Why?
|
Administration, Rectal | 1 | 2016 | 70 | 0.030 |
Why?
|
Trinitrobenzenesulfonic Acid | 1 | 2016 | 65 | 0.030 |
Why?
|
Oxazolone | 1 | 2016 | 61 | 0.030 |
Why?
|
Lens, Crystalline | 1 | 1999 | 387 | 0.030 |
Why?
|
Liver | 2 | 2002 | 7512 | 0.030 |
Why?
|
DNA Footprinting | 1 | 1996 | 97 | 0.030 |
Why?
|
Phenotype | 1 | 2014 | 16571 | 0.030 |
Why?
|
Cyclosporine | 1 | 1998 | 778 | 0.030 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2016 | 254 | 0.030 |
Why?
|
Genetic Complementation Test | 1 | 1996 | 555 | 0.030 |
Why?
|
NAD | 1 | 2019 | 614 | 0.030 |
Why?
|
Coronary Vessels | 1 | 2007 | 3095 | 0.030 |
Why?
|
Inflammation | 2 | 2005 | 10760 | 0.030 |
Why?
|
Response Elements | 2 | 2009 | 309 | 0.030 |
Why?
|
Biological Transport | 1 | 2019 | 2089 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2009 | 8542 | 0.030 |
Why?
|
Blotting, Northern | 1 | 1996 | 1545 | 0.030 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2016 | 344 | 0.030 |
Why?
|
Dendritic Cells | 1 | 2005 | 2722 | 0.030 |
Why?
|
Gene Library | 1 | 1996 | 1055 | 0.030 |
Why?
|
HIV-1 | 1 | 2010 | 6858 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2022 | 2456 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2002 | 6074 | 0.030 |
Why?
|
Clone Cells | 1 | 1996 | 1657 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2022 | 2864 | 0.030 |
Why?
|
Young Adult | 2 | 2016 | 59179 | 0.020 |
Why?
|
Strongylida Infections | 1 | 2011 | 48 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2013 | 17878 | 0.020 |
Why?
|
Fibroblasts | 1 | 2022 | 4137 | 0.020 |
Why?
|
Erythroid-Specific DNA-Binding Factors | 1 | 1991 | 195 | 0.020 |
Why?
|
Gene Expression | 3 | 2011 | 7568 | 0.020 |
Why?
|
Breast Neoplasms | 2 | 2009 | 20988 | 0.020 |
Why?
|
Research Design | 1 | 2007 | 6174 | 0.020 |
Why?
|
Gene Rearrangement, T-Lymphocyte | 1 | 1990 | 111 | 0.020 |
Why?
|
Neoplastic Stem Cells | 2 | 2009 | 1350 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2002 | 10754 | 0.020 |
Why?
|
GATA1 Transcription Factor | 1 | 1991 | 296 | 0.020 |
Why?
|
Blotting, Southern | 1 | 1990 | 777 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2007 | 8998 | 0.020 |
Why?
|
Immunoglobulin Constant Regions | 1 | 1989 | 58 | 0.020 |
Why?
|
Risk Factors | 1 | 2016 | 74115 | 0.020 |
Why?
|
Asthma | 1 | 2008 | 6233 | 0.020 |
Why?
|
Cell Membrane | 1 | 1999 | 3680 | 0.020 |
Why?
|
Binding, Competitive | 1 | 1990 | 1141 | 0.020 |
Why?
|
Crohn Disease | 2 | 2016 | 2279 | 0.020 |
Why?
|
Genes, Immunoglobulin | 1 | 1989 | 285 | 0.020 |
Why?
|
B-Lymphocytes | 2 | 2006 | 4745 | 0.020 |
Why?
|
Interleukin-9 | 1 | 2008 | 62 | 0.020 |
Why?
|
Colon | 1 | 2016 | 1791 | 0.020 |
Why?
|
Immunoglobulin Variable Region | 1 | 1989 | 419 | 0.020 |
Why?
|
U937 Cells | 1 | 2008 | 261 | 0.020 |
Why?
|
Multigene Family | 1 | 1991 | 1076 | 0.020 |
Why?
|
Animals, Newborn | 2 | 2006 | 2668 | 0.020 |
Why?
|
Mammary Glands, Human | 1 | 2009 | 202 | 0.020 |
Why?
|
Chickens | 1 | 2009 | 858 | 0.020 |
Why?
|
Keratin-13 | 1 | 2006 | 11 | 0.020 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2008 | 306 | 0.020 |
Why?
|
Lymphoma | 1 | 1996 | 1899 | 0.020 |
Why?
|
Hemolysis | 1 | 1989 | 415 | 0.020 |
Why?
|
Protein Interaction Mapping | 1 | 2010 | 615 | 0.020 |
Why?
|
Mammary Glands, Animal | 1 | 2008 | 272 | 0.020 |
Why?
|
Biological Evolution | 1 | 1992 | 1070 | 0.020 |
Why?
|
Adoptive Transfer | 1 | 2008 | 818 | 0.020 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2001 | 3415 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2010 | 2747 | 0.020 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 1990 | 687 | 0.020 |
Why?
|
Chromosome Deletion | 1 | 1990 | 1386 | 0.020 |
Why?
|
Lysine | 1 | 2010 | 993 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 2016 | 3031 | 0.020 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2009 | 561 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2007 | 39063 | 0.020 |
Why?
|
Dogs | 1 | 2009 | 3838 | 0.010 |
Why?
|
Hyperplasia | 1 | 2008 | 1150 | 0.010 |
Why?
|
Stroke | 1 | 2007 | 9712 | 0.010 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2005 | 360 | 0.010 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2005 | 277 | 0.010 |
Why?
|
Colitis, Ulcerative | 1 | 2016 | 1921 | 0.010 |
Why?
|
Plasmids | 1 | 1989 | 2265 | 0.010 |
Why?
|
L-Selectin | 1 | 2004 | 211 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 2008 | 2010 | 0.010 |
Why?
|
Cattle | 1 | 2009 | 3841 | 0.010 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2009 | 1348 | 0.010 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2008 | 823 | 0.010 |
Why?
|
Interleukin-12 Subunit p35 | 1 | 2002 | 21 | 0.010 |
Why?
|
Chemokine CCL2 | 1 | 2005 | 602 | 0.010 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2005 | 691 | 0.010 |
Why?
|
Antigen-Presenting Cells | 1 | 2006 | 963 | 0.010 |
Why?
|
Nucleoproteins | 1 | 2002 | 113 | 0.010 |
Why?
|
Internet | 1 | 2014 | 3090 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 1990 | 4110 | 0.010 |
Why?
|
Clostridium Infections | 1 | 1989 | 557 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 1999 | 9172 | 0.010 |
Why?
|
Molecular Structure | 1 | 2006 | 1878 | 0.010 |
Why?
|
Embryonic Development | 1 | 2006 | 721 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2007 | 58894 | 0.010 |
Why?
|
Skin Transplantation | 1 | 2006 | 1083 | 0.010 |
Why?
|
Evolution, Molecular | 1 | 2009 | 1880 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 1996 | 14648 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2006 | 1670 | 0.010 |
Why?
|
Allergens | 1 | 2008 | 1429 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2008 | 3777 | 0.010 |
Why?
|
Lymphocytic Choriomeningitis | 1 | 2001 | 139 | 0.010 |
Why?
|
Kidney | 2 | 2010 | 7045 | 0.010 |
Why?
|
Eosinophils | 1 | 2004 | 953 | 0.010 |
Why?
|
Macrophage Activation | 1 | 2002 | 552 | 0.010 |
Why?
|
Tissue Plasminogen Activator | 1 | 2005 | 1163 | 0.010 |
Why?
|
Genomic Library | 1 | 1999 | 189 | 0.010 |
Why?
|
HLA-DP Antigens | 1 | 1998 | 25 | 0.010 |
Why?
|
Genes, bcl-2 | 1 | 1998 | 119 | 0.010 |
Why?
|
Mice, Inbred DBA | 1 | 1999 | 619 | 0.010 |
Why?
|
Transgenes | 1 | 2001 | 1008 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2008 | 4910 | 0.010 |
Why?
|
Acute Kidney Injury | 1 | 1989 | 1924 | 0.010 |
Why?
|
Mice, Inbred NOD | 1 | 2001 | 1827 | 0.010 |
Why?
|
Lymphocyte Count | 1 | 1998 | 778 | 0.010 |
Why?
|
Stem Cells | 1 | 2009 | 3516 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2008 | 3672 | 0.010 |
Why?
|
Cell Movement | 1 | 2008 | 5200 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2005 | 3206 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2004 | 2413 | 0.010 |
Why?
|
Sepsis | 1 | 1989 | 2585 | 0.010 |
Why?
|
Islets of Langerhans | 1 | 2001 | 1340 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2008 | 11069 | 0.010 |
Why?
|
Algorithms | 1 | 2014 | 14018 | 0.010 |
Why?
|
Pancreatitis | 1 | 2001 | 1097 | 0.010 |
Why?
|
Rats | 1 | 2009 | 23717 | 0.010 |
Why?
|
Immunoglobulin E | 1 | 1999 | 1502 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2008 | 9417 | 0.010 |
Why?
|
Disease Progression | 1 | 2008 | 13495 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2008 | 6340 | 0.010 |
Why?
|
Blood Pressure | 1 | 2005 | 8472 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1992 | 1738 | 0.010 |
Why?
|
Methylation | 1 | 1992 | 1077 | 0.010 |
Why?
|
Clostridium perfringens | 1 | 1989 | 29 | 0.010 |
Why?
|
Child | 1 | 2016 | 80079 | 0.000 |
Why?
|
Cholecystitis | 1 | 1989 | 180 | 0.000 |
Why?
|
Adolescent | 1 | 2016 | 88234 | 0.000 |
Why?
|
Mutation | 1 | 1990 | 30016 | 0.000 |
Why?
|
Diabetes Mellitus | 1 | 2001 | 5835 | 0.000 |
Why?
|
Aging | 1 | 1999 | 8699 | 0.000 |
Why?
|